Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Role of Comorbidities in Treatment and Outcomes after Chronic Obstructive Pulmonary Disease Exacerbations.

Spece LJ, Epler EM, Donovan LM, Griffith MF, Collins MP, Feemster LC, Au DH.

Ann Am Thorac Soc. 2018 Aug 4. doi: 10.1513/AnnalsATS.201804-255OC. [Epub ahead of print]

PMID:
30079748
2.

Regulation of V-ATPase Assembly in Nutrient Sensing and Function of V-ATPases in Breast Cancer Metastasis.

Collins MP, Forgac M.

Front Physiol. 2018 Jul 13;9:902. doi: 10.3389/fphys.2018.00902. eCollection 2018. Review.

3.

The nonsystemic vasculitic neuropathies.

Collins MP, Hadden RD.

Nat Rev Neurol. 2017 Apr 27;13(5):302-316. doi: 10.1038/nrneurol.2017.42. Review.

PMID:
28447661
4.

Follicles first.

Murphy SM, Connor JO, Collins MP.

J Plast Reconstr Aesthet Surg. 2017 Mar;70(3):425-426. doi: 10.1016/j.bjps.2016.11.032. Epub 2017 Jan 7. No abstract available.

PMID:
28118987
5.

Development of Eosinophilic Fasciitis during Infliximab Therapy for Psoriatic Arthritis.

Hariman R, Patel P, Strouse J, Collins MP, Rosenthal A.

Case Rep Rheumatol. 2016;2016:7906013. doi: 10.1155/2016/7906013. Epub 2016 May 11.

6.

Predictors of Pharmacotherapy for Tobacco Use Among Veterans Admitted for COPD: The Role of Disparities and Tobacco Control Processes.

Melzer AC, Feemster LC, Collins MP, Au DH.

J Gen Intern Med. 2016 Jun;31(6):623-9. doi: 10.1007/s11606-016-3623-4. Epub 2016 Feb 22.

7.

Utilization and effectiveness of pharmacotherapy for tobacco use following admission for exacerbation of COPD.

Melzer AC, Feemster LC, Collins MP, Au DH.

J Hosp Med. 2016 Apr;11(4):257-63. doi: 10.1002/jhm.2519. Epub 2015 Dec 14.

8.

Vasculitic peripheral neuropathy: Case definition and guidelines for collection, analysis, and presentation of immunisation safety data.

Hadden RDM, Collins MP, Živković SA, Hsieh ST, Bonetto C, Felicetti P, Marchione P, Santuccio C, Bonhoeffer J; Brighton Collaboration Vasculitic Peripheral Neuropathy Working Group.

Vaccine. 2017 Mar 13;35(11):1567-1578. doi: 10.1016/j.vaccine.2015.11.047. Epub 2015 Dec 2. No abstract available.

PMID:
26655629
9.

BAG3 myofibrillar myopathy presenting with cardiomyopathy.

Konersman CG, Bordini BJ, Scharer G, Lawlor MW, Zangwill S, Southern JF, Amos L, Geddes GC, Kliegman R, Collins MP.

Neuromuscul Disord. 2015 May;25(5):418-22. doi: 10.1016/j.nmd.2015.01.009. Epub 2015 Feb 4.

PMID:
25728519
10.

Comments on 'gait disturbance due to foot drop is refractory to treatment in nonsystemic vasculitic neuropathy'.

Collins MP, Hadden RD.

Eur Neurol. 2015;73(1-2):78-9. doi: 10.1159/000368224. Epub 2014 Nov 12. No abstract available.

11.

Vasculitic neuropathies.

Gwathmey KG, Burns TM, Collins MP, Dyck PJ.

Lancet Neurol. 2014 Jan;13(1):67-82. doi: 10.1016/S1474-4422(13)70236-9. Review.

PMID:
24331794
12.

Hearing aid effectiveness after aural rehabilitation: individual versus group trial results.

Collins MP, Liu CF, Taylor L, Souza PE, Yueh B.

J Rehabil Res Dev. 2013;50(4):585-98.

13.

The neuropathies of vasculitis.

Collins MP, Arnold WD, Kissel JT.

Neurol Clin. 2013 May;31(2):557-95. doi: 10.1016/j.ncl.2013.01.007. Epub 2013 Feb 23. Review.

PMID:
23642724
14.

The vasculitic neuropathies: an update.

Collins MP.

Curr Opin Neurol. 2012 Oct;25(5):573-85. doi: 10.1097/WCO.0b013e3283580432. Review.

PMID:
22918487
15.

Isopropylammonium formate as a mobile phase modifier for liquid chromatography.

Collins MP, Zhou L, Camp SE, Danielson ND.

J Chromatogr Sci. 2012 Nov-Dec;50(10):869-76. doi: 10.1093/chromsci/bms084. Epub 2012 Jun 19.

16.

Mitochondrial myopathy due to novel missense mutation in the cytochrome c oxidase 1 gene.

Massie R, Wang J, Chen LC, Zhang VW, Collins MP, Wong LJ, Milone M.

J Neurol Sci. 2012 Aug 15;319(1-2):158-63. doi: 10.1016/j.jns.2012.05.003. Epub 2012 May 24.

PMID:
22632780
17.

Discovery of (+)-N-(3-aminopropyl)-N-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide (AZD4877), a kinesin spindle protein inhibitor and potential anticancer agent.

Theoclitou ME, Aquila B, Block MH, Brassil PJ, Castriotta L, Code E, Collins MP, Davies AM, Deegan T, Ezhuthachan J, Filla S, Freed E, Hu H, Huszar D, Jayaraman M, Lawson D, Lewis PM, Nadella MV, Oza V, Padmanilayam M, Pontz T, Ronco L, Russell D, Whitston D, Zheng X.

J Med Chem. 2011 Oct 13;54(19):6734-50. doi: 10.1021/jm200629m. Epub 2011 Sep 7.

PMID:
21899292
18.

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.

Suppiah R, Hadden RD, Batra R, Arden NK, Collins MP, Guillevin L, Jayne DR, Luqmani RA; European Vasculitis Study Group.

Rheumatology (Oxford). 2011 Dec;50(12):2214-22. doi: 10.1093/rheumatology/ker266. Epub 2011 Sep 2.

PMID:
21890618
19.

Resistance of renal cell carcinoma to sorafenib is mediated by potentially reversible gene expression.

Zhang L, Bhasin M, Schor-Bardach R, Wang X, Collins MP, Panka D, Putheti P, Signoretti S, Alsop DC, Libermann T, Atkins MB, Mier JW, Goldberg SN, Bhatt RS.

PLoS One. 2011 Apr 29;6(4):e19144. doi: 10.1371/journal.pone.0019144.

20.

Long-term cost-effectiveness of screening strategies for hearing loss.

Liu CF, Collins MP, Souza PE, Yueh B.

J Rehabil Res Dev. 2011;48(3):235-43.

21.

Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary.

Collins MP, Dyck PJ, Gronseth GS, Guillevin L, Hadden RD, Heuss D, Léger JM, Notermans NC, Pollard JD, Said G, Sobue G, Vrancken AF, Kissel JT; Peripheral Nerve Society.

J Peripher Nerv Syst. 2010 Sep;15(3):176-84. doi: 10.1111/j.1529-8027.2010.00281.x.

PMID:
21040139
22.

Renal cancer resistance to antiangiogenic therapy is delayed by restoration of angiostatic signaling.

Bhatt RS, Wang X, Zhang L, Collins MP, Signoretti S, Alsop DC, Goldberg SN, Atkins MB, Mier JW.

Mol Cancer Ther. 2010 Oct;9(10):2793-802. doi: 10.1158/1535-7163.MCT-10-0477. Epub 2010 Aug 10.

23.

Direct immunofluoresence in vasculitic neuropathy: specificity of vascular immune deposits.

Collins MP, Periquet-Collins I, Sahenk Z, Kissel JT.

Muscle Nerve. 2010 Jul;42(1):62-9. doi: 10.1002/mus.21639.

PMID:
20544917
24.

The additional yield of combined nerve/muscle biopsy in vasculitic neuropathy.

Vrancken AF, Gathier CS, Cats EA, Notermans NC, Collins MP.

Eur J Neurol. 2011 Jan;18(1):49-58. doi: 10.1111/j.1468-1331.2010.03041.x.

PMID:
20482601
25.

Long-term effectiveness of screening for hearing loss: the screening for auditory impairment--which hearing assessment test (SAI-WHAT) randomized trial.

Yueh B, Collins MP, Souza PE, Boyko EJ, Loovis CF, Heagerty PJ, Liu CF, Hedrick SC.

J Am Geriatr Soc. 2010 Mar;58(3):427-34. doi: 10.1111/j.1532-5415.2010.02738.x.

PMID:
20398111
26.

Hearing aid effectiveness after aural rehabilitation - individual versus group (HEARING) trial: RCT design and baseline characteristics.

Collins MP, Souza PE, Liu CF, Heagerty PJ, Amtmann D, Yueh B.

BMC Health Serv Res. 2009 Dec 15;9:233. doi: 10.1186/1472-6963-9-233.

27.

Nonsystemic vasculitic neuropathy: update on diagnosis, classification, pathogenesis, and treatment.

Collins MP, Periquet-Collins I.

Front Neurol Neurosci. 2009;26:26-66. doi: 10.1159/000212368. Epub 2009 Apr 6. Review.

PMID:
19349704
28.

Isolated vasculitis of the peripheral nervous system.

Collins MP, Periquet MI.

Clin Exp Rheumatol. 2008 May-Jun;26(3 Suppl 49):S118-30. Review.

PMID:
18799069
29.

Effectiveness of group versus individual hearing aid visits.

Collins MP, Souza PE, O'Neill S, Yueh B.

J Rehabil Res Dev. 2007;44(5):739-49.

30.

Antineutrophil cytoplasmic antibodies in nonsystemic vasculitic neuropathy.

Collins MP.

J Rheumatol. 2007 Apr;34(4):899-900. No abstract available.

PMID:
17407256
31.

Screening for Auditory Impairment-Which Hearing Assessment Test (SAI-WHAT): RCT design and baseline characteristics.

Yueh B, Collins MP, Souza PE, Heagerty PJ, Liu CF, Boyko EJ, Loovis CF, Fausti SA, Hedrick SC.

Contemp Clin Trials. 2007 May;28(3):303-15. Epub 2006 Aug 30.

PMID:
17030153
32.

Localized vasculitis and the peripheral nervous system.

Collins MP.

J Rheumatol. 2005 May;32(5):769-72. Review. No abstract available.

PMID:
15868607
33.

The effects of meditation and visual imagery on an immune system disorder: dermatomyositis.

Collins MP, Dunn LF.

J Altern Complement Med. 2005 Apr;11(2):275-84.

PMID:
15865493
34.

Non-systemic vasculitic neuropathy.

Collins MP, Periquet MI.

Curr Opin Neurol. 2004 Oct;17(5):587-98. Review.

PMID:
15367863
35.

Nonsystemic vasculitic neuropathy: insights from a clinical cohort.

Collins MP, Periquet MI, Mendell JR, Sahenk Z, Nagaraja HN, Kissel JT.

Neurology. 2003 Sep 9;61(5):623-30.

PMID:
12963752
36.

Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan.

Biroscak BJ, Fiore AE, Fasano N, Fineis P, Collins MP, Stoltman G.

Pediatrics. 2003 Jun;111(6 Pt 1):e645-9.

PMID:
12777580
37.

Prevalence of vasculitic neuropathy in Wegener granulomatosis.

Collins MP, Periquet MI.

Arch Neurol. 2002 Aug;59(8):1333-4; author reply 1334. No abstract available.

PMID:
12164733
38.

Hypocapnia and other ventilation-related risk factors for cerebral palsy in low birth weight infants.

Collins MP, Lorenz JM, Jetton JR, Paneth N.

Pediatr Res. 2001 Dec;50(6):712-9.

PMID:
11726729
39.

Randomized trial of amplification strategies.

Yueh B, Souza PE, McDowell JA, Collins MP, Loovis CF, Hedrick SC, Ramsey SD, Deyo RA.

Arch Otolaryngol Head Neck Surg. 2001 Oct;127(10):1197-204.

PMID:
11587599
40.

Autonomic impairment in painful neuropathy.

Novak V, Freimer ML, Kissel JT, Sahenk Z, Periquet IM, Nash SM, Collins MP, Mendell JR.

Neurology. 2001 Apr 10;56(7):861-8.

PMID:
11294922
41.

Application of acoustic emission to the monitoring and end point determination of a high shear granulation process.

Whitaker M, Baker GR, Westrup J, Goulding PA, Rudd DR, Belchamber RM, Collins MP.

Int J Pharm. 2000 Sep 15;205(1-2):79-92.

PMID:
11000544
42.

Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy.

Collins MP, Mendell JR, Periquet MI, Sahenk Z, Amato AA, Gronseth GS, Barohn RJ, Jackson CE, Kissel JT.

Neurology. 2000 Sep 12;55(5):636-43.

PMID:
10980725
43.

Vasculitic neuropathy in chronic graft-versus-host disease (GVHD)

Collins MP, Periquet MI.

J Neurol Sci. 2000 Apr 1;175(1):71-3. No abstract available.

PMID:
10905885
44.

Painful sensory neuropathy: prospective evaluation using skin biopsy.

Periquet MI, Novak V, Collins MP, Nagaraja HN, Erdem S, Nash SM, Freimer ML, Sahenk Z, Kissel JT, Mendell JR.

Neurology. 1999 Nov 10;53(8):1641-7.

PMID:
10563606
45.

Neuropathies associated with malignancy.

Amato AA, Collins MP.

Semin Neurol. 1998;18(1):125-44. Review.

PMID:
9562674
46.

A migratory infiltrate in a patient with hemoptysis and chest pain.

Ghio AJ, Elliott CG, Crapo RO, Collins MP, Tocino I.

Chest. 1989 Jul;96(1):195-6. No abstract available.

PMID:
2736974
47.

Traumatic rupture of the pulmonary artery.

Collins MP, Robinson GC.

Ann Thorac Surg. 1989 Apr;47(4):612-3.

PMID:
2712636
48.

Management of refractory empyema with early decortication.

Muskett A, Burton NA, Karwande SV, Collins MP.

Am J Surg. 1988 Dec;156(6):529-32.

PMID:
3202267
49.

Sporothrix schenckii endophthalmitis in a patient with human immunodeficiency virus infection.

Kurosawa A, Pollock SC, Collins MP, Kraff CR, Tso MO.

Arch Ophthalmol. 1988 Mar;106(3):376-80.

PMID:
3257867
50.

Meningioma and transient global amnesia: another report.

Collins MP, Freeman JW.

Neurology. 1986 Apr;36(4):594. No abstract available.

PMID:
3960342

Supplemental Content

Loading ...
Support Center